<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Biosion Announces First Patient Dosed in Investigator-Initiated Phase 1 Trial of BSI-082, a Next-Generation Anti-SIRPα Monoclonal Antibody for Advanced Solid Tumors	</title>
	<atom:link href="https://9krapalm.com/biosion-announces-first-patient-dosed-in-investigator-initiated-phase-1-trial-of-bsi-082-a-next-generation-anti-sirp%ce%b1-monoclonal-antibody-for-advanced-solid-tumors/feed/" rel="self" type="application/rss+xml" />
	<link>https://9krapalm.com/biosion-announces-first-patient-dosed-in-investigator-initiated-phase-1-trial-of-bsi-082-a-next-generation-anti-sirp%ce%b1-monoclonal-antibody-for-advanced-solid-tumors/</link>
	<description>เสิร์ฟข่าวไอที อัปเดตเทคโนโลยีสไตล์ @krapalm</description>
	<lastBuildDate>Tue, 03 Feb 2026 10:15:28 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0.1</generator>
</channel>
</rss>
